PhysIOL to Launch FineVision Triumf Trifocal EDOF IOL

BVI, through its PhysIOL subsidiary, announced the European launch of the FineVision Triumf EDOF trifocal presbyopia correcting IOL. Results from a year of clinical studies will be presented at the European Society for Cataract and Refractive Surgeons (ESCRS), held September 14-17, in Paris, France.

The FineVision was the world’s first trifocal lens launched 9 years ago. The FineVision Triumf is designed to improve intermediate vision, particularly important for the changing lifestyle of patients. In addition, the FineVision Triumf combines trifocal technology and EDOF optics with the goal of reducing low light condition side effects, which are resulting toward glare and halos experienced by some patients after implantation of trifocal IOLs. These undesirable effects are the result of longitudinal chromatic aberration (LCA)–different colors bend at slightly different degrees when passing through the lens. The FineVision Triumf is free of LCA at far and intermediate focus points where glare and halos appear. This results in higher contrast sensitivity, less risk of photic phenomena, and improved quality of vision in low light conditions, according to PhysIOL.

“The unique FineVision Triumf gives my patients a seamless and continuous vision from near over intermediate to distance as shown by the innovative monotonic defocus curve whilst the chromatic aberration correction translates into a superior optical quality of vision,” Erik Mertens, MD, FEBOphth, Belgium, said in a company news release.

The FineVision Triumf lens is available in Europe and certain international markets. Activities are underway to make the technology available in the US, China, and other markets outside Europe as soon as possible.